ITOC iTonic Holdings Ltd Annual reports only
Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1970544
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY16.7%
TTM net income YoY-671.7%
TTM EPS YoY-511.5%
Revenue 3-yr CAGR-8.4%
Net income 3-yr CAGR—
Margins
Gross margin62.6%
Operating margin-991.7%
Net margin-974.7%
FCF margin-618.6%
EBITDA margin—
Returns
ROE-82.8%
ROA-64.5%
ROIC (approx.)-176.0%
Asset turnover0.07x
Leverage & solvency
Liabilities / assets10.7%
Debt / equity0.00x
Current ratio8.83x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.63x
Accruals ratio-23.6%
Payout ratio—
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $523,031 | $448,196 |
| Cost of revenue | $195,680 | $67,041 |
| Gross profit | $327,351 | $381,155 |
| R&D expense | $459,135 | $93,324 |
| SG&A expense | $4.87M | $750,563 |
| Operating income | -$5.19M | -$770,266 |
| Pretax income | -$5.10M | -$638,759 |
| Income tax | — | $21,829 |
| Net income | -$5.10M | -$660,588 |
| EPS (basic) | -0.32 | -0.05 |
| EPS (diluted) | -0.32 | -0.05 |
| Weighted avg. shares (diluted) | 16.04M | 12.72M |
| Balance sheet | ||
| Cash & equivalents | $1.49M | $6.16M |
| Short-term investments | $1.44M | — |
| Receivables | $288,456 | $281,585 |
| Inventory | $52,479 | $117,422 |
| Current assets | $4.09M | $6.68M |
| PP&E, net | $37,818 | $45,594 |
| Goodwill | $1.96M | — |
| Intangibles | $2.41M | — |
| Total assets | $9.10M | $6.72M |
| Current liabilities | $462,817 | $538,551 |
| Total liabilities | $969,832 | $538,551 |
| Shareholders' equity | $6.12M | $6.18M |
| Cash flow statement | ||
| Operating cash flow | -$3.23M | -$775,000 |
| Capital expenditure | $3,806 | $861 |
| Free cash flow | -$3.24M | -$775,861 |
| Investing cash flow | -$1.35M | -$861 |
| Financing cash flow | -$91,645 | $6.71M |
| Stock-based compensation | $2.95M | — |
| Dividends paid | $8,907 | — |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.